Benzoic acid,2-(acetyloxy)-,mixt. with N-(4-ethoxyphenyl)acetamide,5-ethyl-5-(3-methylbutyl)-2,4,6(1H,3H,5H)- pyrimidinetrione and (RS)-R-methylbenzeneethanamine sulfate (2:1) (71628-71-2)

Other Product

• 2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-ethyl-5-phenyl-, mixt. with (+-)-alpha-methylbenzeneethanamine sulfate (2:1)
• 2,4,6(1H,3H,5H)-Pyrimidinetrione,5-ethyl-5- (3-methylbutyl)-,mixt. with 5-(1-methylbutyl)-5-(2-propenyl)-2,4,6(1H,- 3H,5H)-pyrimidinetrione
• Acetamide,N-(4-ethoxyphenyl)-,mixt. with 3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6- dione,4-(dimethylamino)-1,2-dihydro-1,5- dimethyl-2-phenyl-3H-pyrazol-3-one and 5-ethyl-5-phenyl-2,4,6(1H,3H,5H)- pyrimidinetrione
• 2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-ethyl-5-(3-methylbutyl)-, monosodi um salt, mixt. with 5-(1-methylbutyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-p yrimidinetrione monosodium salt
• Acetamide,N-(4-ethoxyphenyl)-,mixt. with 5,5-diethyl-2,4,6(1H,3H,5H)-pyrimidinetrione,3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6- dione and 4-(dimethylamino)-1,2-dihydro-1,- 5-dimethyl-2-phenyl-3H-pyrazol-3-one
• Morphinan-6-ol,7,8-didehydro-4,5-epoxy-3- methoxy-17-methyl-,(5R,6R)-,phosphate (1:1) (salt),mixt. with 3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6- dione,4-(dimethylamino)-1,2-dihydro-1,5- dimethyl-2-phenyl-3H-pyrazol-3-one,N-(4-ethoxyphenyl)acetamide and 5-ethyl-5-phenyl-2,4,6(1H,3H,5H)- pyrimidinetrione
• Morphinan-6-ol, 7,8-didehydro-4,5-epoxy-3-methoxy-17-methyl-, (5alpha,6alpha)-, phosphate (1:1) (salt), mixt. with 2-(acetyloxy)benzoic acid, 3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6-dione and 5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione
• Benzenepropanaminium, gamma-(aminocarbonyl)-N-methyl-N,N-bis(1-methylethyl)-gamma-phenyl-, iodide, mixt. with 3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6-dione, (S-(R*,S*))-6,7-dimethoxy-3-(5,6,7,8-tetrahydro-4-methoxy-6-methyl-1,3-dioxolo(4,5-g)isoquinolin-5-yl)-1(3H)-isobenzofuranone hydrochloride, 5-ethyl-5-(3-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione and N-(4-hydroxyphenyl)acetamide
• Benzoic acid,2-(acetyloxy)-,mixt. with 5-(2-butenyl)-5-ethyl-2,4,6(1H,3H,5H)- pyrimidinetrione and 3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6- dione
• 2,4,6(1H,3H,5H)-Pyrimidinetrione,5-ethyl-5- (1-methylbutyl)-,calcium salt (2:1),mixt. with N,N-dimethyl-10H-phenothiazine-10- propanamine
• Benzeneacetic acid,R-phenyl-,2-(diethylamino)- ethyl ester,hydrochloride,mixt. with 5-ethyl-5-phenyl-2,4,6(1H,3H,5H)- pyrimidinetrione
• 2,4,6(1H,3H,5H)-Pyrimidinetrione,5-ethyl-5- (3-methylbutyl)-,mixt. with 3,7-dihydro-1,3-dimethyl-1H-purine-2,6- dione compd. with 1,2-ethanediamine (2:1) and (RR)-R-[(1S)-1-(methylamino)ethyl]- benzenemethanol
• Benzoic acid, 2-hydroxy-, calcium salt (2:1), compd. with 3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione (1:1), mixt. with 5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione, (R-(R*,S*))-alpha-(1-(methylamino)ethyl)benzenemethanol hydrochloride and potassium iodide (KI)
• 2,4,6(1H,3H,5H)-Pyrimidinetrione,5-ethyl-5-(2-methylbutyl)-
• Ergotaman-3,6,18-trione, 9,10-dihydro-12-hydroxy-2-methyl-5-(phenylmethyl)-, (5alpha,10alpha)-, (R-(R*,R*))-2,3-dihydroxybutanedioate (2:1) (salt), mixt. with (5alpha,6alpha)-7,8-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol phosphate (1:1) (salt), 3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6-dione and 5-ethyl-5-(3-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione
• 2,4,6(1H,3H,5H)-Pyrimidinetrione,5-ethyl-5-(3-methylbutyl)-1,3-di-2-propen-1-yl-
• 2,4,6(1H,3H,5H)-Pyrimidinetrione,1-(2-bromobenzoyl)-5-ethyl-5-(3-methylbutyl)-
• 1(3H)-Isobenzofuranone,6,7-dimethoxy-3- [(5R)-5,6,7,8-tetrahydro-4-methoxy-6- methyl-1,3-dioxolo[4,5-g]isoquinolin-5-yl]-,hydrochloride,(3S)-,mixt. with rel-(RS)-R-[(1R)-1-(dimethylamino)ethyl]- benzenemethanol hydrochloride and 2-(diphenylmethoxy)-N,N-dimethylethanamine hydrochloride
• 2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-(1-cyclohexen-1-yl)-5-ethyl-, mixt. with 4-(dimethylamino)-1,2-dihydro-1,5-dimethyl-2-phenyl-3H-pyrazol-3-one
• 2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-[[5-(diethylamino)-2-furanyl]methylene]-1-(4-ethoxyphenyl)-